TNFSF10 and chronic kidney disease: Specifically, the lowest levels of TRAIL were observed in patients with at least one new hypoechoic plaque after 24 months-follow up in the carotid artery (p = 0.013), even after adjusting for CKD stage (p = 0.015), a well-recognized factor for plaque composition.